Press Release Archive

01.30.2009

Pfizer Discontinues Global Phase III Trial of Axitinib for Futility in Advanced Pancreatic Cancer

01.29.2009

Geodon Proven Effective as Adjunctive Maintenance Treatment of Bipolar Disorder

01.27.2009

Pfizer Invites Public to Listen to Audio-Only Webcast of January 27 Investor Luncheon

01.25.2009

MEDIA ADVISORY: Pfizer and Wyeth to Host Live Press Conference in New York

01.25.2009

Pfizer Reports Fourth-Quarter and Full-Year 2008 Results and 2009 Financial Guidance

01.25.2009

Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company

01.16.2009

Pfizer Receives FDA Complete Response Letter for Lasofoxifene

01.13.2009

Stephen W. Sanger Elected to Pfizer’s Board of Directors

01.06.2009

U.S. Patent and Trademark Office Accepts Pfizer’s Reissue Application on Lipitor Enantiomer Patent

12.21.2008

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

12.21.2008

Bradley E. Lerman Joins Pfizer as Senior Vice President of Litigation

12.15.2008

Pfizer Declares a 32-Cent First-Quarter 2009 Dividend

12.14.2008

Pfizer Invites Public to View and Listen to Webcast of January 28 Conference Call with Analysts

12.11.2008

Pfizer Announces Results from Trial of AROMASIN in Postmenopausal Women with Hormone Sensitive Early Breast Cancer

12.08.2008

Pfizer and Sigma-Tau Announce an Agreement to Market a Potential New Treatment for Malaria in Africa

12.02.2008

Patients Taking Lipitor Had a Significantly Reduced Risk of Cardiovascular Events Compared with Patients Taking Simvastatin, New Observational Study Shows

11.25.2008

Pfizer’s Novel HIV/AIDS Treatment SELZENTRY™ Becomes the Latest Fully Approved Antiretrovial for Treatment-Experienced HIV Patients

11.19.2008

Pfizer Withdraws Application to Switch Viagra to Non-Prescription Status in Europe

11.13.2008

Pfizer Launches Global Regenerative Medicine Research Unit

11.11.2008

New Analysis Suggests That Improvements in Kidney Function in Patients Treated with Lipitor Strongly Correlate with a Reduced Risk of Major Cardiovascular Events

11.05.2008

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

11.05.2008

Pfizer Discontinues Development Program for Its Phase 3 Obesity Compound (CP-945,598)

10.31.2008

Pfizer's TOVIAZ(TM) (fesoterodine fumarate) Receives FDA Approval for the Treatment of Overactive Bladder

10.26.2008

Pfizer's Novel HIV/AIDS Treatment Selzentry(TM) (Maraviroc) Demonstrates Increased Efficacy Rate In Treatment-Naive HIV Patients

10.25.2008

Pfizer to Present Data on New Approaches to Pain and Inflammation Treatment at ACR Meeting

10.23.2008

Pfizer Declares a 32-Cent Fourth-Quarter 2008 Dividend

10.22.2008

Pfizer Completes Settlement Agreements with State Attorneys General Regarding its NSAID Pain Medications

10.21.2008

Pfizer Names New Head of Clinical Development and Medical Affairs for Its Oncology Business Unit

10.20.2008

Pfizer Reports Third-Quarter 2008 Results

10.19.2008

Pfizer and UCB Announce Formation of New Company 'Cyclofluidic' to Accelerate Drug Discovery Process

10.16.2008

Pfizer Reaches Agreements in Principle to Resolve Litigation Involving Its NSAID Pain Medications

10.13.2008

New Data across Pfizer's Pain and Inflammation Portfolio to Be Presented at Upcoming ACR Meeting

10.09.2008

Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements over Four Years

10.09.2008

Aetna and Pfizer Present ''State of Motion'' Health Fair in Hartford to Encourage Families to Adopt Healthy Lifestyles

10.08.2008

EPA Honors Pfizer for Reducing Greenhouse Gas Emissions

10.03.2008

Pfizer Invites Public to View and Listen to Webcast of October 28 Analyst and Investor Meeting at ACR

10.01.2008

Pfizer Invites Public to View and Listen to Webcast of October 21 Conference Call with Analysts

09.30.2008

Pfizer Shows Accelerating Pipeline with Significant Growth in Late-Stage Clinical Development

09.24.2008

Established Safety Profile of Spiriva(R) Confirmed by 30 Rigorously Controlled Clinical Trials

09.23.2008

Grameen Health and Pfizer Announce Novel Partnership to Explore Sustainable Healthcare Delivery Models for the Developing World

09.22.2008

Pfizer Recognized as Leader in Improving Climate Change for Second Consecutive Year

09.15.2008

MannKind and Pfizer Announce Collaboration for Certain Exubera Patients to Transition to MannKind's Inhaled Insulin Therapy

09.15.2008

Pfizer Launches New Medicine Safety Website to Help Healthcare Professionals and Patients Make Better Informed Decisions about Treatment Options

09.14.2008

Pfizer Oncology Presents Safety and Efficacy Results Of CP-751,871 Study At ESMO 2008

09.10.2008

Pfizer Animal Health Adds Former Schering-Plough Products to European Portfolio

09.08.2008

Pfizer Will Withdraw Global Marketing Applications for Dalbavancin to Conduct a New Trial

09.08.2008

Data to Be Presented At ESMO 2008 Highlight Pfizer Commitment to Cancer Care and Research

09.08.2008

Pfizer Invites Public to View and Listen to Webcast of Pfizer Participation at Healthcare Conference